Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132

Aspasia Athina Volakaki, Daniel Lafkas, Eva Kassi, Andrew V Schally, Athanasios G. Papavassiliou, Hippokratis Kiaris

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

GHRH, besides its neuroendocrine action in controlling the release of GH from the pituitary, stimulates the growth of various cancers in vivo and in vitro by direct mechanism(s). However, the molecular mechanism that mediates these proliferative effects of GHRH in extrapituitary tissues remains poorly characterized. In the present study, we investigated whether the tumor suppressor p21/waf1 is involved in the mediation of the proliferative effects of GHRH in A549 human lung cancer epithelial cells. Exposure of A549 cells to the GHRH antagonist JMR-132 caused a significant inhibition in the rate of cell proliferation. In A549 cells, GHRH suppressed while JMR-132 increased the levels of p21 expression in a dose-dependent manner. This suggests that GHRH could regulate p21 levels. We then evaluated whether p21 is required in A549 cells for the regulation of cell proliferation by GHRH. To this end, we knocked-down p21 expression in A549 cells by siRNA and assessed the effects of antagonist JMR-132 on cell proliferation. We found that the loss of p21 expression abolished the anti-proliferative effects of JMR-132. Suppression of p21 expression by siRNA in human HT29 colon cancer cells and non-transformed mouse osteoblasts KS483 also blocked the anti-proliferative effects of JMR-132 suggesting that the regulation of cell proliferation by GHRH is p21 dependent. These results shed light on the molecular mechanism of action of GHRH antagonists in tumor tissues and suggest that the antineoplastic activity of GHRH antagonists could be considered for the treatment of cancers expressing p21.

Original languageEnglish
Pages (from-to)389-392
Number of pages4
JournalJournal of Molecular Endocrinology
Volume41
Issue number5-6
DOIs
StatePublished - Nov 1 2008

Fingerprint

Cell Proliferation
Small Interfering RNA
Neoplasms
Osteoblasts
Antineoplastic Agents
Colonic Neoplasms
Lung Neoplasms
Epithelial Cells
PhAcTyr(1)-Arg(2)-P(H)e(4-CL)(6)-Ala(8)-Tyr(Me)(10)-His(11)-Abu(15)-His(20)-Nle(27)-Arg(28)-HLCr(29)-gHRH(1-29)NH2
A549 Cells
Growth

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology

Cite this

Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132. / Volakaki, Aspasia Athina; Lafkas, Daniel; Kassi, Eva; Schally, Andrew V; Papavassiliou, Athanasios G.; Kiaris, Hippokratis.

In: Journal of Molecular Endocrinology, Vol. 41, No. 5-6, 01.11.2008, p. 389-392.

Research output: Contribution to journalArticle

Volakaki, Aspasia Athina ; Lafkas, Daniel ; Kassi, Eva ; Schally, Andrew V ; Papavassiliou, Athanasios G. ; Kiaris, Hippokratis. / Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132. In: Journal of Molecular Endocrinology. 2008 ; Vol. 41, No. 5-6. pp. 389-392.
@article{a1e856914c9d46f2bf598e61bdd03c68,
title = "Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132",
abstract = "GHRH, besides its neuroendocrine action in controlling the release of GH from the pituitary, stimulates the growth of various cancers in vivo and in vitro by direct mechanism(s). However, the molecular mechanism that mediates these proliferative effects of GHRH in extrapituitary tissues remains poorly characterized. In the present study, we investigated whether the tumor suppressor p21/waf1 is involved in the mediation of the proliferative effects of GHRH in A549 human lung cancer epithelial cells. Exposure of A549 cells to the GHRH antagonist JMR-132 caused a significant inhibition in the rate of cell proliferation. In A549 cells, GHRH suppressed while JMR-132 increased the levels of p21 expression in a dose-dependent manner. This suggests that GHRH could regulate p21 levels. We then evaluated whether p21 is required in A549 cells for the regulation of cell proliferation by GHRH. To this end, we knocked-down p21 expression in A549 cells by siRNA and assessed the effects of antagonist JMR-132 on cell proliferation. We found that the loss of p21 expression abolished the anti-proliferative effects of JMR-132. Suppression of p21 expression by siRNA in human HT29 colon cancer cells and non-transformed mouse osteoblasts KS483 also blocked the anti-proliferative effects of JMR-132 suggesting that the regulation of cell proliferation by GHRH is p21 dependent. These results shed light on the molecular mechanism of action of GHRH antagonists in tumor tissues and suggest that the antineoplastic activity of GHRH antagonists could be considered for the treatment of cancers expressing p21.",
author = "Volakaki, {Aspasia Athina} and Daniel Lafkas and Eva Kassi and Schally, {Andrew V} and Papavassiliou, {Athanasios G.} and Hippokratis Kiaris",
year = "2008",
month = "11",
day = "1",
doi = "10.1677/JME-08-0106",
language = "English",
volume = "41",
pages = "389--392",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "5-6",

}

TY - JOUR

T1 - Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132

AU - Volakaki, Aspasia Athina

AU - Lafkas, Daniel

AU - Kassi, Eva

AU - Schally, Andrew V

AU - Papavassiliou, Athanasios G.

AU - Kiaris, Hippokratis

PY - 2008/11/1

Y1 - 2008/11/1

N2 - GHRH, besides its neuroendocrine action in controlling the release of GH from the pituitary, stimulates the growth of various cancers in vivo and in vitro by direct mechanism(s). However, the molecular mechanism that mediates these proliferative effects of GHRH in extrapituitary tissues remains poorly characterized. In the present study, we investigated whether the tumor suppressor p21/waf1 is involved in the mediation of the proliferative effects of GHRH in A549 human lung cancer epithelial cells. Exposure of A549 cells to the GHRH antagonist JMR-132 caused a significant inhibition in the rate of cell proliferation. In A549 cells, GHRH suppressed while JMR-132 increased the levels of p21 expression in a dose-dependent manner. This suggests that GHRH could regulate p21 levels. We then evaluated whether p21 is required in A549 cells for the regulation of cell proliferation by GHRH. To this end, we knocked-down p21 expression in A549 cells by siRNA and assessed the effects of antagonist JMR-132 on cell proliferation. We found that the loss of p21 expression abolished the anti-proliferative effects of JMR-132. Suppression of p21 expression by siRNA in human HT29 colon cancer cells and non-transformed mouse osteoblasts KS483 also blocked the anti-proliferative effects of JMR-132 suggesting that the regulation of cell proliferation by GHRH is p21 dependent. These results shed light on the molecular mechanism of action of GHRH antagonists in tumor tissues and suggest that the antineoplastic activity of GHRH antagonists could be considered for the treatment of cancers expressing p21.

AB - GHRH, besides its neuroendocrine action in controlling the release of GH from the pituitary, stimulates the growth of various cancers in vivo and in vitro by direct mechanism(s). However, the molecular mechanism that mediates these proliferative effects of GHRH in extrapituitary tissues remains poorly characterized. In the present study, we investigated whether the tumor suppressor p21/waf1 is involved in the mediation of the proliferative effects of GHRH in A549 human lung cancer epithelial cells. Exposure of A549 cells to the GHRH antagonist JMR-132 caused a significant inhibition in the rate of cell proliferation. In A549 cells, GHRH suppressed while JMR-132 increased the levels of p21 expression in a dose-dependent manner. This suggests that GHRH could regulate p21 levels. We then evaluated whether p21 is required in A549 cells for the regulation of cell proliferation by GHRH. To this end, we knocked-down p21 expression in A549 cells by siRNA and assessed the effects of antagonist JMR-132 on cell proliferation. We found that the loss of p21 expression abolished the anti-proliferative effects of JMR-132. Suppression of p21 expression by siRNA in human HT29 colon cancer cells and non-transformed mouse osteoblasts KS483 also blocked the anti-proliferative effects of JMR-132 suggesting that the regulation of cell proliferation by GHRH is p21 dependent. These results shed light on the molecular mechanism of action of GHRH antagonists in tumor tissues and suggest that the antineoplastic activity of GHRH antagonists could be considered for the treatment of cancers expressing p21.

UR - http://www.scopus.com/inward/record.url?scp=57749104694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57749104694&partnerID=8YFLogxK

U2 - 10.1677/JME-08-0106

DO - 10.1677/JME-08-0106

M3 - Article

C2 - 18765563

AN - SCOPUS:57749104694

VL - 41

SP - 389

EP - 392

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 5-6

ER -